ID: ALA91199

Max Phase: Preclinical

Molecular Formula: C7H9NO5

Molecular Weight: 187.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)C(=O)N1CCCC1C(=O)O

Standard InChI:  InChI=1S/C7H9NO5/c9-5(7(12)13)8-3-1-2-4(8)6(10)11/h4H,1-3H2,(H,10,11)(H,12,13)

Standard InChI Key:  ULLHRTLURBDLBB-UHFFFAOYSA-N

Associated Targets(non-human)

P4ha1 Prolyl 4-hydroxylase alpha-1 subunit (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 187.15Molecular Weight (Monoisotopic): 187.0481AlogP: -0.85#Rotatable Bonds: 1
Polar Surface Area: 94.91Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.54CX Basic pKa: CX LogP: -0.53CX LogD: -7.40
Aromatic Rings: 0Heavy Atoms: 13QED Weighted: 0.52Np Likeness Score: -0.18

References

1. Cunliffe CJ, Franklin TJ, Hales NJ, Hill GB..  (1992)  Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives.,  35  (14): [PMID:1321909] [10.1021/jm00092a016]

Source